Found: 24
Select item for more details and to access through your institution.
Screening of an FDA-Approved Library for Novel Drugs against Y. pestis.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 1, p. 40, doi. 10.3390/antibiotics10010040
- By:
- Publication type:
- Article
Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 581, doi. 10.3390/vaccines11030581
- By:
- Publication type:
- Article
Early sensing of Yersinia pestis airway infection by bone marrow cells.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2012, v. 2, p. 1, doi. 10.3389/fcimb.2012.00143
- By:
- Publication type:
- Article
Transendothelial migration of effector T cells across inflamed endothelial barriers does not require heparan sulfate proteoglycans.
- Published in:
- International Immunology, 2014, v. 26, n. 6, p. 315, doi. 10.1093/intimm/dxt076
- By:
- Publication type:
- Article
Yopp-Expressing Variant of<i>Y. pestis</i> Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083560
- By:
- Publication type:
- Article
The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0007023
- By:
- Publication type:
- Article
Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005938
- By:
- Publication type:
- Article
Adjunctive Corticosteroid Treatment Against Yersinia pestis Improves Bacterial Clearance, Immunopathology, and Survival in the Mouse Model of Bubonic Plague.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of Improved Devices for Handling and Restraining Experimental Laboratory Mice.
- Published in:
- Applied Biosafety: Journal of the American Biological Safety Association, 2020, v. 25, n. 1, p. 53, doi. 10.1177/1535676019892068
- By:
- Publication type:
- Article
The mesenchyme expresses T cell receptor mRNAs: relevance to cell growth control.
- Published in:
- Oncogene, 2002, v. 21, n. 13, p. 2029, doi. 10.1038/sj.onc.1205269
- By:
- Publication type:
- Article
Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection.
- Published in:
- Microorganisms, 2021, v. 9, n. 10, p. 2166, doi. 10.3390/microorganisms9102166
- By:
- Publication type:
- Article
Involvement of p21<sup>WAF1/Cip1</sup>, CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition.
- Published in:
- Oncogene, 1997, v. 15, n. 14, p. 1705, doi. 10.1038/sj.onc.1201348
- By:
- Publication type:
- Article
Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 6, p. 1, doi. 10.1371/journal.pntd.0007449
- By:
- Publication type:
- Article
An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis.
- Published in:
- Pathogens, 2022, v. 11, n. 2, p. 255, doi. 10.3390/pathogens11020255
- By:
- Publication type:
- Article
Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2017, v. 7, p. 1, doi. 10.3389/fcimb.2017.00277
- By:
- Publication type:
- Article
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/v14040688
- By:
- Publication type:
- Article
Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 5, p. 1, doi. 10.1371/journal.ppat.1004893
- By:
- Publication type:
- Article
Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75840-w
- By:
- Publication type:
- Article
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 45, doi. 10.3390/antib10040045
- By:
- Publication type:
- Article
Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model.
- Published in:
- Frontiers in Microbiology, 2018, p. 1, doi. 10.3389/fmicb.2018.00741
- By:
- Publication type:
- Article
Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 9, p. 952, doi. 10.3390/cells8090952
- By:
- Publication type:
- Article
Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21239-8
- By:
- Publication type:
- Article
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18159-4
- By:
- Publication type:
- Article